October 31, 2013
Ranbaxy Inc. launched suit in New Jersey federal court Tuesday alleging pharmaceutical giant Actavis Inc. has infringed its patent for acne drug Absorica by seeking federal approval to launch a generic version of the drug before the patent expires.